Skip to content
  • Wednesday, 28 October 2026
  • 12:00 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I
Laboratory Automation & Robotics

DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I

Lana Keisha Oct 26, 2026 0

In a decisive regulatory move aimed at curbing the proliferation of high-potency, synthetic psychoactive substances, the U.S. Drug Enforcement Administration…

Read More
Laboratory Automation & Robotics

DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I

Lana Keisha Oct 12, 2026 0

In a decisive move to address the burgeoning public health risks associated with the proliferation of synthetic, highly potent derivatives…

Read More
Laboratory Automation & Robotics

DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I

Lana Keisha Oct 4, 2026 0

The United States Drug Enforcement Administration (DEA) has initiated a significant regulatory crackdown on a burgeoning class of semi-synthetic alkaloids…

Read More
Laboratory Automation & Robotics

DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I

Lana Keisha Sep 26, 2026 0

The United States Drug Enforcement Administration (DEA) has initiated a significant regulatory crackdown on a burgeoning class of synthetic alkaloids…

Read More
Laboratory Automation & Robotics

DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I

Lana Keisha Sep 19, 2026 0

The United States Drug Enforcement Administration (DEA) has officially moved to curtail the proliferation of highly potent, synthetic derivatives associated…

Read More
Laboratory Automation & Robotics

DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I

Lana Keisha Sep 12, 2026 0

In a significant move to address the rising proliferation of potent, lab-engineered substances, the U.S. Drug Enforcement Administration (DEA) has…

Read More
Biotech & Genetic Research

AMSBIO Reports Karolinska Institutet’s Groundbreaking Research Using AAV Products to Uncover Neural Basis of Rheumatoid Arthritis Pain

Jia Lissa May 14, 2026 0

AMSBIO, a leading provider of life science reagents and services, has announced its involvement in a pivotal research endeavor by…

Read More
Advanced Materials Science

Nagoya University Researchers Achieve Breakthrough in Sustainable Iron Photocatalysis for the Asymmetric Total Synthesis of Complex Natural Products

Nila Kartika Wati Mar 26, 2026 0

In a significant advancement for the field of organic chemistry, a research team at Nagoya University’s Graduate School of Engineering…

Read More
Cornell Researchers Develop Microscale Neural Implant Capable of Long-Term Wireless Brain MonitoringCNPV: A gamechanger for the pharma industry or simply more chaos?RIKEN Physicists Propose Breakthrough Method for Robust One-Way Quantum Synchronization of PhononsLinkedIn Report Unveils Critical Skills Driving the Future of Clinical Laboratory Careers Amidst Evolving Healthcare Landscape
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ